alnylam
Alnylam Pharmaceuticals is seeking a Director of Statistical Programming to lead and oversee statistical programming activities in clinical development. The role involves managing teams, ensuring quality and compliance for regulatory submissions, and collaborating across functions and vendors. The position demands extensive experience in SAS programming, clinical trial data analysis, and leadership within a biopharmaceutical setting.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Right around the average for this role
CON-Statistical Programmer
Xencor
Sr. Manager/AD, Statistical Programmer
Beam Therapeutics
Associate Director, Statistical Programming
Corcept Therapeutics
Associate Director, Statistical Programming
AstraZeneca
Statistical Programming Contractor
CRISPR Therapeutics
Associate Director, Statistical Programming
Verastem